1. Home >
  2. M&A >
  3. Venture >
  4. China >
  5. Eight Roads Invests In TreeENT

Investment Summary

Eight Roads Invests In TreeENT

On February 26, 2019, private equity firm Eight Roads invested in healthcare services company TreeENT

Investment Highlights
  • This is Eight Roads’ 11th transaction in the Healthcare Services sector.
  • This is Eight Roads’ 45th transaction in China.

Investment Summary
Date 2019-02-26
Target TreeENT
Sector Healthcare Services
Investor(s) Eight Roads
Deal Type Venture

Target

TreeENT

Hangzhou, China
TreeENT is an otolaryngology specialist chain covering areas such as suppurative otitis media, allergic rhinitis, chronic sinusitis and thyroid cancer. It provides users with Danish ear hearing detection, nasal endoscopy video examination and nasopharyngoscopy, specialists test report interpretation and other services; and can use WeChat appointment appointment time, appointment hospital experts. TreeENT was founded in 2016 and is based in Hangzhou, China.

Search 214,356 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

Eight Roads

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 1969
PE ASSETS 11.0B USD
Size Mega
Type Sector Focused
DESCRIPTION

Eight Roads is a private investment firm focused on a variety of investment opportunities across the US, Europe, and Asia. The Firm is divided into several investment strategies including venture, principal investing, and real estate. Within the principal investments group, Eight Roads backs established growth businesses with long-term capital. Eight Roads does not have any sector preferences, but has experience in fintech, business services, and healthcare. Eight Roads is based in London.

DEAL STATS #
Overall 208 of 293
Sector: Healthcare Services M&A 11 of 16
Type: Venture M&A Deals 185 of 266
Country: China M&A 45 of 66
Year: 2019 M&A 7 of 21
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2019-02-01 Arvelle Therapeutics

Zug, Switzerland

Arvelle Therapeutics is an emerging biopharmaceutical company focused on bringing innovative treatments to patients suffering from CNS disorders. Arvelle Therapeutics was founded in 2019 and is based in Zug, Switzerland.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2019-03-06 Beam Therapeutics

Cambridge, Massachusetts, United States

Beam Therapeutics is a biotechnology company that builds a strong, values-driven organization focused on people, advancing cutting-edge science, and rigorously developing a new class of precision genetic medicines. The company engages in developing precision genetic medicines for patients suffering from serious diseases in the United States. Beam Therapeutics was founded in 2017 and is headquartered in Cambridge, Massachusetts.

Buy -
Mergr

Solution for

Product

Company

Legal